* Biomarker discovery in Parkinson's disease (PD) is challenging due to late-stage symptom emergence and limited access to high-quality datasets.
* The Biomedical Intelligence Cloud offers access to curated datasets, aiding in biomarker identification and drug target discovery for PD.
* The Parkinson's disease resource collection in the Biomedical